human leukemic t cell lines jurkat (e6-1) (CEM Corporation)
Structured Review

Human Leukemic T Cell Lines Jurkat (E6 1), supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human leukemic t cell lines jurkat (e6-1)/product/CEM Corporation
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Lymphoid susceptibility to the Aggregatibacter actinomycetemcomitans cytolethal distending toxin (Cdt) is dependent upon baseline levels of the signaling lipid, phosphatidylinositol-3,4,5-triphosphate"
Article Title: Lymphoid susceptibility to the Aggregatibacter actinomycetemcomitans cytolethal distending toxin (Cdt) is dependent upon baseline levels of the signaling lipid, phosphatidylinositol-3,4,5-triphosphate
Journal: Molecular oral microbiology
doi: 10.1111/omi.12127
Figure Legend Snippet: Comparison of the effects of Cdt on toxicity in Jurkat and HUT78 cells. Jurkat cells were treated with medium alone (panel A) or Cdt (2.0 pg/ml) for 16–20 hr and cell cycle distribution determined following staining with propidium iodide (PI) and analysis by flow cytometry. Panels C and D show HUT78 cells in the presence of medium alone or Cdt, respectively. In addition to cell cycle, the effects of Cdt on apoptosis was assessed using the TUNEL assay; Panels E and F show the results from Jurkat cells in the presence of medium and Cdt (25 pg/ml), respectively, 48 hr after exposure to toxin. Results with HUT78 cells are shown in panels G (medium only) and H (Cdt). Numbers in each panel represent the percentage of G2 cells or apoptotic cells. Panels I and J show the aggregate results from three experiments each performed in duplicate; *indicate P<0.05 when compared to control Jurkat cells and ** indicates P<0.05 when compared to Cdt-treated Jurkat cells.
Techniques Used: Comparison, Staining, Flow Cytometry, TUNEL Assay, Control
Figure Legend Snippet: Baseline analysis of components of the PI-3K signaling pathway. Panel A shows a representative Western blot for pAkt, Akt, pGSK3β (pGSK), GSK3β (GSK) and GAPDH for Jurkat cells, CCRM-CEM cells and HUT78 cells. Panel B shows the aggregate results for three experiments; results are expressed as a percentage of Jurkat cell density. Panel C shows the results of PIP3 levels and represent the mean SEM. *indicate P<0.05 when compared to control Jurkat cells
Techniques Used: Western Blot, Control
Figure Legend Snippet: Analysis of Jurkat cells reconstituted with PTEN. Panel A shows the baseline PIP3 levels were measured in Jurkat cells reconstituted with PTEN: controls (Con18) and pten transfection (PIJ-12); these cells were assessed under non-induced and induced conditions. Values are pmol PIP3/106 cells and represent the mean ± SEM of three replicate experiments; *indicate P<0.05 when compared to uninduced cells treated with Cdt. Panel B shows the effect of Cdt holotoxin on PIJ-12 and Con 18 cell lines which were treated with doxycycline as well as cells maintained under non-induced conditions. The percentage of G2 cells is plotted versus Cdt concentration. The mean ± SEM is shown for three experiments; *indicate P<0.05 when compared touninduced cells treated with Cdt.
Techniques Used: Transfection, Concentration Assay
Figure Legend Snippet: Flow cytometric analysis of the binding of Cdt holotoxin and internalization of CdtB in Jurkat cells and HUT78 cells. Jurkat cells (panels A and B) and HUT78 cells (panels C and D) were exposed to medium (panels A and C) or Cdt (panels B and D). Cells were then stained for surface association of Cdt holotoxin (anti-CdtC mAb) or internalization of CdtB (anti-CdtB mAb). The mean channel fluorescence (MCF) is indicated in each panel for both control cells not exposed to Cdt (grey curve) and toxin treated cells (black line). The mean MCF ± SEM for three experiments is shown in panel E; *indicate P<0.05 when compared to control cells.
Techniques Used: Binding Assay, Staining, Fluorescence, Control


![Activated PKD2 was immunoprecipitated from lysate of <t>Jurkat</t> cells stimulated with anti-CD3ε antibody. The heat-inactivated (50°C, 5 min) Jurkat nuclear extract was used as a substrate for PKD2 and analyzed by 2D-gel electrophoresis. (A) Activated PKD2 was incubated with the nuclear extracts in the presence of [γ- 32 P]-ATP and Gö6983 (an irrelevant PKC inhibitor) and the radioactivity of 2D-electrophregram was detected. (B) Activated PKD2 was incubated with the nuclear extracts in the presence of [γ- 32 P]-ATP and Gö6976 (PKD2 inhibitor) and the radioactivity of 2D-electrophoregram was detected. (C) The proteins in the Jurkat nuclear extract treated with non-radioactive ATP and PKD2 were stained with syproruby. Inset; the enlarged view of the boxed area. A protein spot indicated by the asterisks, which overlaps to the radioactive spots indicated in A or in B was analyzed by mass spectrometry. (D) One of the MS/MS spectra assigned to be SET protein is shown (m/z = 604, 110 VEVTEFEDIK 119 ).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_2678/pmc03522678/pmc03522678__pone.0051242.g001.jpg)